Kathy Whitney

When Rob Hood, M.D., began practicing cardiology 30 years ago he could not have imagined that fitness would one day be measured on a device worn around his wrist. Read More

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression. Read More

Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). Read More

At 6 feet 4 inches, Shea Weber towers over the tiny tots he visits at Monroe Carell Jr. Children’s Hospital at Vanderbilt, yet it is he who looks up to them. Read More

Ray Harris, M.D., has been elected president of the American Society of Nephrology during the society’s annual meeting, ASN Kidney Week 2015, in San Diego. Read More

People with high fitness levels in midlife have significantly lower annual health care costs after age 65 than people with low fitness in midlife, after adjusting for cardiovascular risk factors, according to a study published in the Journal of the American College of Cardiology (JACC). Read More

Howard Baum, M.D., assistant professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, has been elected vice president (physician-in-practice) of The Endocrine Society. Read More

As part of its ongoing commitment to provide excellent care for heart failure patients in Tennessee and the Southeastern U.S., Vanderbilt Heart and Vascular Institute recently became the first medical center in the state to implant the HeartMate 3, a novel mechanical circulatory support device. Vanderbilt… Read More

Ashish Shah, M.D., has joined Vanderbilt Heart and Vascular Institute (VHVI) as director of Heart Transplant and Mechanical Circulatory Support. Read More

Vanderbilt University Medical Center is hosting the first Global Cardio-Oncology Summit on Oct. 15-16, at the Hilton Nashville. The summit models a leading edge, interdisciplinary approach to cardio-oncology. Read More

The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation. Read More

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys. Read More

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older. Read More

In April 1986 Bonnie Davis of Mt. Pleasant, Tennessee, became the first female patient to receive a heart transplant at Vanderbilt University Hospital. On Oct. 3, she will return to campus to participate in the Greater Nashville Heart Walk. Read More

Joshua Beckman, M.D., MSc., previously a faculty member at Harvard Medical School and Brigham and Women’s Hospital, has been named director of Vanderbilt’s newly formed Section of Vascular Medicine within the Division of Cardiovascular Medicine. Read More

For patients with heart failure, changes in pulmonary artery (PA) pressures are an early indication that their condition is worsening, even before they notice symptoms such as shortness of breath or weight gain. Read More

A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research. Read More

The American College of Cardiology has recognized Vanderbilt University Medical Center (VUMC) for its commitment to and success in implementing a higher standard of care for heart attack patients. Read More

Robert F. Heimburger, M.D., a member of the Vanderbilt University School of Medicine class of 1943, died June 9. He was 97. Read More

Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin. Read More